Patrick Burnett's Net Worth
$3.05 Million
Who is Patrick Burnett?
Patrick Burnett has an estimated net worth of $3.05 Million. This is based on reported shares across multiple companies, which include Arcutis Biotherapeutics, Inc., and Verrica Pharmaceuticals Inc..
SEC CIK
Patrick Burnett's CIK is 0001741987
Past Insider Trading and Trends
2024 was Patrick Burnett's most active year for acquiring shares with 7 total transactions. Patrick Burnett's most active month to acquire stocks was the month of January. 2024 was Patrick Burnett's most active year for disposing of shares, totalling 10 transactions. Patrick Burnett's most active month to dispose stocks was the month of February. 2020 saw Patrick Burnett paying a total of $0.00 for 408,500 shares, this is the most they've acquired in one year. In 2024 Patrick Burnett cashed out on 563,314 shares for a total of $778,068.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.92% | -15.44K |
$8.68 | -$134,092.73 | 179.42K |
Scheduled
|
Nov 4
| ||
Form 4
| -19.23% | -49.95K |
$8.73 | -$636,705.63 | 209.79K |
May 29 - May 30
| |||
Form 4
| -3.55% | -9.55K |
$8.74 | -$83,489.68 | 259.75K |
Scheduled
|
May 2
| ||
Form 4
| -1.74% | -4.78K |
$11.12 | -$53,181.58 | 269.3K |
Scheduled
|
Mar 4
| ||
Form 4
| +222.33% | 189.05K |
—
|
—
| 274.08K |
Feb 13
| |||
Form 4
| +49.10% | 28K |
—
|
—
| 85.03K |
Jan 12
| |||
Form 4
| -2.27% | -1.32K |
$3.54 | -$4,691.56 | 57.03K |
Jan 2
| |||
Form 4
| -2.68% | -1.60K |
$7.04 | -$11,302.20 | 58.36K |
Aug 21
| |||
Form 4
| -1.40% | -851.00 |
$15.26 | -$12,989.15 | 59.96K |
Scheduled
|
Mar 6
| ||
Form 4
| +46.31% | 19.25K |
$15.83 | -$27,713.12 | 60.81K |
Scheduled
|
Mar 2
| ||
Form 4
| -3.43% | -1.48K |
$15.01 | -$22,136.06 | 41.56K |
Jan 3
| |||
Form 4
| +63.96% | 16.79K |
$16.85 | -$17,032.12 | 43.04K |
Scheduled
|
Mar 3 - Mar 7
| ||
Form 4
| +176.32% | 16.75K |
—
|
—
| 26.25K |
Dec 30
| |||
Form 4
|
∞
| 9.5K |
—
|
—
| 9.5K |
Mar 3
| |||
Form 4
|
∞
| 33.5K |
—
|
—
| 33.5K |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verrica Pharmaceuticals Inc. (VRCA) Snapshot price: $1.9099
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||